CS logo
small CS logo
Klinika Chorob Metabolicznych Instytut

Warsaw, Poland
Medical laboratory in Warsaw
Powsińska 61, 02-903 Warszawa

About Klinika Chorob Metabolicznych Instytut


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Genzyme, a Sanofi Company
2
Total Rows: 1

Clinical Trials at Klinika Chorob Metabolicznych Instytut


During the past decade, Klinika Chorob Metabolicznych Instytut conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of the Safety and Efficacy of Fabrazyme (Agalsidase Beta) as Compared to Placebo in Patients With Advanced Fabry Disease
2001-02-01
2004-01-01
Completed
82
A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease
2004-01-01
2005-09-01
Completed
67

Rows per page:

1–2 of 2

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading SponsorsGenzyme, a Sanofi Company: 2Genzyme, a Sanofi Company: 2

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Klinika Chorob Metabolicznych Instytut


According to Clinical.Site data, the most researched conditions in "Klinika Chorob Metabolicznych Instytut" are "Fabry Disease" (2 trials). Many other conditions were trialed in "Klinika Chorob Metabolicznych Instytut" in a lesser frequency.

Clinical Trials Intervention Types at Klinika Chorob Metabolicznych Instytut


Most popular intervention types in "Klinika Chorob Metabolicznych Instytut" are "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Fabrazyme (agalsidase beta)" (1 trials), "Placebo" (1 trials) and "agalsidase beta" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Klinika Chorob Metabolicznych Instytut


The vast majority of trials in "Klinika Chorob Metabolicznych Instytut" are 2 trials for "All" genders.

Clinical Trials Status at Klinika Chorob Metabolicznych Instytut


Currently, there are NaN active trials in "Klinika Chorob Metabolicznych Instytut". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Klinika Chorob Metabolicznych Instytut, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Klinika Chorob Metabolicznych Instytut, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 4: 2Phase 4: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 2Completed: 2